VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,241 | -34.4% | 3,065 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $20,198 | +71.0% | 3,065 | +76.1% | 0.00% | 0.0% |
| Q1 2023 | $11,815 | -55.4% | 1,740 | -51.5% | 0.00% | 0.0% |
| Q4 2022 | $26,515 | -25.2% | 3,588 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $35,449 | -9.4% | 3,588 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $39,109 | -3.6% | 3,588 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $40,580 | -82.5% | 3,588 | -75.8% | 0.00% | -66.7% |
| Q4 2021 | $232,290 | +1.0% | 14,805 | +10.3% | 0.00% | 0.0% |
| Q3 2021 | $230,002 | -34.4% | 13,419 | -17.7% | 0.00% | -40.0% |
| Q2 2021 | $350,591 | +59.3% | 16,299 | +11.2% | 0.01% | +66.7% |
| Q1 2021 | $220,058 | +33.7% | 14,651 | +16.9% | 0.00% | +50.0% |
| Q4 2020 | $164,631 | +0.3% | 12,529 | -26.3% | 0.00% | -33.3% |
| Q3 2020 | $164,162 | -15.6% | 16,994 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $194,411 | +10.4% | 16,994 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $176,058 | -34.3% | 16,994 | +4.1% | 0.00% | 0.0% |
| Q4 2019 | $267,975 | +17.4% | 16,330 | -5.0% | 0.00% | 0.0% |
| Q3 2019 | $228,243 | -5.7% | 17,187 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $242,165 | -23.4% | 17,187 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $316,241 | -29.6% | 17,187 | 0.0% | 0.01% | -33.3% |
| Q4 2018 | $449,096 | +13.9% | 17,187 | 0.0% | 0.01% | +28.6% |
| Q3 2018 | $394,442 | -99.9% | 17,187 | 0.0% | 0.01% | +40.0% |
| Q2 2018 | $327,412,000 | +33.9% | 17,187 | +18.4% | 0.01% | +66.7% |
| Q1 2018 | $244,594,000 | +110576.0% | 14,516 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $221,000 | -54.2% | 14,516 | -51.0% | 0.00% | 0.0% |
| Q2 2017 | $483,000 | +16.7% | 29,606 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $414,000 | -12.3% | 29,606 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $472,000 | -4.3% | 29,606 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $493,000 | +48.9% | 29,606 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $331,000 | +33.5% | 29,606 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $248,000 | -10.1% | 29,606 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $276,000 | -17.4% | 29,606 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $334,000 | -11.2% | 29,606 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $376,000 | +27.0% | 29,606 | -7.0% | 0.00% | +50.0% |
| Q1 2015 | $296,000 | -35.1% | 31,839 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $456,000 | +74.0% | 31,839 | +25.9% | 0.00% | +50.0% |
| Q3 2014 | $262,000 | -35.9% | 25,280 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $409,000 | -0.5% | 25,280 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $411,000 | +30.9% | 25,280 | 0.0% | 0.00% | +50.0% |
| Q4 2013 | $314,000 | +13.4% | 25,280 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $277,000 | +35.8% | 25,280 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $204,000 | – | 25,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |